首頁 > 市場調查報告書 > 製藥

再生醫學細胞療法

市場調查報告書

商品編碼

1567185

GMP 細胞治療耗材市場：按產品類型、按細胞類型、按應用、按最終用戶、按地區

GMP Cell Therapy Consumables Market, By Product Type, By Cell Type, By Application, By End User, By Geography

出版日期: 2024年08月28日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球GMP細胞治療耗材市場規模為1,404萬美元，預估2031年將達8,003萬美元，2024年至2031年複合年成長率為28.2%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	1404萬美元
實際資料	2019-2023	預測期	2024年至2031年
預測 2024-2031 年複合年成長率：	28.20%	2031年價值預測	8003萬美元

圖：2024 年按地區分類的 GMP 細胞治療耗材市場佔有率

全球 GMP 細胞治療耗材市場的成長是由癌症等慢性疾病盛行率日益上升所推動的。細胞療法涉及從患者或捐贈者的體內提取細胞並對其進行改造以對抗疾病。 GMP 耗材透過在細胞治療產品的開發和製造過程中確保無菌並防止污染，在細胞治療程序中發揮重要作用。細胞研究資金增加、易患慢性病的老年人口不斷增加以及醫療保健支出不斷增加等因素可能會推動全球細胞治療中 GMP 耗材的需求。然而，與細胞療法開發相關的高成本和有關 GMP 設施的嚴格監管指南可能會阻礙市場成長。

市場動態：

全球 GMP 細胞治療耗材市場的成長是由全球癌症和其他慢性病發病率上升等因素所推動的。根據世界衛生組織統計，2018年，癌症新病例增加至1,810萬，死亡人數增加至960萬。這增加了對細胞療法等先進治療解決方案的需求，以及對 GMP 耗材的需求。公共和私人組織增加對細胞研究的投資可能會推動市場成長。例如，美國國立衛生研究院在 2022 年為細胞療法研究撥款超過 1.5 億美元。然而，開發細胞療法和維護 GMP 設施相關的高成本可能會阻礙市場成長。嚴格的 GMP 生產監管標準可能會阻礙細胞治療產品的廣泛商業化。此外，與細胞治療相關的報銷問題可能會阻礙市場成長。 GMP 耗材的持續技術進步以簡化製造流程並增加細胞治療的應用可以為市場參與者提供成長機會。

本研究的主要特點

該報告對全球 GMP 細胞治療耗材市場進行了詳細分析，並提供了以 2023 年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。

它揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，了解全球 GMP 細胞治療耗材市場的主要企業概況。

主要公司包括 Merck KGaA、Danaher Corporation、Sartorius AG、Thermo Fisher Scientific、General Electric、PBS Biotech 和 Meissner Filtration Products。

該報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

全球 GMP 細胞治療耗材市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

透過用於分析全球 GMP 細胞治療耗材市場的各種策略矩陣，將促進相關人員的決策。

Thermo Fisher Scientific Inc.
Lonza Group
Merck KGaA
Corning Inc.
Sartorius AG
Danaher Corporation
Miltenyi Biotec
Stemcell Technologies Inc.
GE Healthcare
Takara Bio Inc.
Bio-Techne Corporation
HiMedia Laboratories
Eppendorf AG
Avantor, Inc.
Beckman Coulter, Inc.
Terumo BCT, Inc.
Roche Diagnostics
Irvine Scientific
Fujifilm Irvine Scientific, Inc.
CellGenix GmbH

第10章分析師建議

命運之輪
分析師觀點
一致的機會圖

第11章參考文獻與調查方法

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI7327

Global GMP cell therapy consumables market is estimated to be valued at USD 14.04 Mn in 2024 and is expected to reach USD 80.03 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 28.2% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 14.04 Mn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	28.20%	2031 Value Projection:	US$ 80.03 Mn

Figure. GMP Cell Therapy Consumables Market Share (%), By Region, 2024

GMP Cell Therapy Consumables Market - IMG1

Global GMP cell therapy consumables market growth is driven by increasing prevalence of chronic diseases like cancer. Cell therapy involves extracting cells from patient's/ donor's body and modifying them to fight against diseases. GMP consumables play a vital role in cell therapy procedures as these ensure sterility and prevent contamination during development and manufacturing of cell therapy products. Factors such as rising funding for cell-based research, growing geriatric population susceptible to chronic illnesses and augmenting healthcare expenditure can boost demand for GMP consumables in cell therapy globally. However, high costs associated with cell therapy developments and stringent regulatory guidelines for GMP facilities can hamper the market growth.

Market Dynamics:

Global GMP cell therapy consumables market growth is driven by factors such as rising incidence of cancer and other chronic illnesses worldwide. As per WHO, cancer burden has increased to 18.1 million new cases and 9.6 million deaths in 2018. This has boosted demand for advanced treatment solutions like cell therapy, thus, boosting the need for GMP consumables. Growing investments in cell-based research by public-private organizations can drive the market growth. For instance, National Institutes of Health granted over US$ 150 million towards cell therapy research in 2022. However, high costs associated with cell therapy development and maintenance of GMP facilities can hamper the market growth. Strict regulatory standards for GMP manufacturing can hamper the wider commercialization of cell therapy products. Moreover, reimbursement issues related to cell therapies can hamper the market growth. Ongoing technological advancements in GMP consumables to simplify manufacturing processes and rising applications of cell therapies can provide growth opportunities for market players.

Key features of the study:

This report provides in-depth analysis of the global GMP cell therapy consumables market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global GMP cell therapy consumables market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Merck KGaA, Danaher Corporation, Sartorius AG, Thermo Fisher Scientific, General Electric, PBS Biotech, Meissner Filtration Products

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global GMP cell therapy consumables market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global GMP cell therapy consumables market

Detailed Segmentation-

Product Type Insights (Revenue, USD Mn, 2019 - 2031)
- Cell Culture Media and Supplements
- Cell Separation and Purification Consumables
- Cryopreservation Consumables
- Cell Transduction Consumables
- Other Consumables (Labware, Bioreactors, etc.)
Cell Type Insights (Revenue, USD Mn, 2019 - 2031)
- Stem Cells (Embryonic, Induced Pluripotent, Adult)
- T-Cells
- Natural Killer (NK) Cells
- Other Cell Types (Dendritic Cells, Chondrocytes, etc.)
Application Insights (Revenue, USD Mn, 2019 - 2031)
- Oncology
- Regenerative Medicine
- Neurology
- Cardiovascular
- Immunology
- Other Applications
End User Insights (Revenue, USD Mn, 2019 - 2031)
- Biopharmaceutical Companies
- Contract Manufacturing Organizations (CMOs)
- Academic and Research Institutions
- Hospitals and Clinics
- Others
By Regional Insights (Revenue, USD Mn 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Thermo Fisher Scientific Inc.
- Lonza Group
- Merck KGaA
- Corning Inc.
- Sartorius AG
- Danaher Corporation
- Miltenyi Biotec
- Stemcell Technologies Inc.
- GE Healthcare
- Takara Bio Inc.
- Bio-Techne Corporation
- HiMedia Laboratories
- Eppendorf AG
- Avantor, Inc.
- Beckman Coulter, Inc.
- Terumo BCT, Inc.
- Roche Diagnostics
- Irvine Scientific
- Fujifilm Irvine Scientific, Inc.
- CellGenix GmbH

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global GMP Cell Therapy Consumables Market, By Product Type
- Global GMP Cell Therapy Consumables Market, By Cell Type
- Global GMP Cell Therapy Consumables Market, By Application
- Global GMP Cell Therapy Consumables Market, By End User
- Global GMP Cell Therapy Consumables Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global GMP Cell Therapy Consumables Market, By Product Type, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Cell Culture Media and Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Cell Separation and Purification Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Cryopreservation Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Cell Transduction Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Other Consumables (Labware, Bioreactors, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

5. Global GMP Cell Therapy Consumables Market, By Cell Type, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Stem Cells (Embryonic, Induced Pluripotent, Adult)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
T-Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Natural Killer (NK) Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Other Cell Types (Dendritic Cells, Chondrocytes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global GMP Cell Therapy Consumables Market, By Application, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global GMP Cell Therapy Consumables Market, By End User, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Contract Manufacturing Organizations (CMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global GMP Cell Therapy Consumables Market, By Region, 2019 - 2031, (USD Mn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2019 - 2031, (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Cell Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Cell Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Cell Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Cell Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Cell Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Cell Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lonza Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA
Corning Inc.
Sartorius AG
Danaher Corporation
Miltenyi Biotec
Stemcell Technologies Inc.
GE Healthcare
Takara Bio Inc.
Bio-Techne Corporation
HiMedia Laboratories
Eppendorf AG
Avantor, Inc.
Beckman Coulter, Inc.
Terumo BCT, Inc.
Roche Diagnostics
Irvine Scientific
Fujifilm Irvine Scientific, Inc.
CellGenix GmbH